U.S. Roadside Drug Testing Market 2030: A $1.62 Billion Solution to Impaired Driving
The U.S. roadside drug testing market size was valued at USD 1.17 billion in 2023 and is projected to grow at a CAGR of 4.71% from 2024 to 2030. The market is likely to show promising growth due to increasing awareness of the danger of drug-impaired driving and rising drug use, especially with the legalization of marijuana in many states. Law enforcement agencies are investing in new technologies for accurate and efficient testing to ensure public safety. Moreover, government regulations and campaigns against impaired driving are boosting the demand for reliable roadside testing solutions. The market expansion is also fueled by rapid technological advancements, enabling quicker and more effective detection of various substances. The rise in fatalities and accidents related to alcohol & substance abuse among drivers has become a significant public safety concern in the U.S. This trend is driving the demand for roadside drug testing as law enforcement and public health officials se...